fig9
Figure 9. Expression of CRGs across GBM pathological stages and histologic grades (A) Expression of FDX1, LIPT1, PDHB, and GLS at different pathological stages; (B) Expression across histologic grades of GBM. *P < 0.05, **P < 0.01, ***P < 0.001, ns: Not significant; CRGs: Cuproptosis-related genes; GLS: glutaminase; GBM: glioblastoma.
